GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bavarian Nordic A/S (OCSE:BAVA) » Definitions » Equity-to-Asset

Bavarian Nordic A/S (OCSE:BAVA) Equity-to-Asset : 0.72 (As of Dec. 2023)


View and export this data going back to 1998. Start your Free Trial

What is Bavarian Nordic A/S Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Bavarian Nordic A/S's Total Stockholders Equity for the quarter that ended in Dec. 2023 was kr10,340 Mil. Bavarian Nordic A/S's Total Assets for the quarter that ended in Dec. 2023 was kr14,353 Mil. Therefore, Bavarian Nordic A/S's Equity to Asset Ratio for the quarter that ended in Dec. 2023 was 0.72.

The historical rank and industry rank for Bavarian Nordic A/S's Equity-to-Asset or its related term are showing as below:

OCSE:BAVA' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.27   Med: 0.67   Max: 0.8
Current: 0.72

During the past 13 years, the highest Equity to Asset Ratio of Bavarian Nordic A/S was 0.80. The lowest was 0.27. And the median was 0.67.

OCSE:BAVA's Equity-to-Asset is ranked better than
56.87% of 1565 companies
in the Biotechnology industry
Industry Median: 0.67 vs OCSE:BAVA: 0.72

Bavarian Nordic A/S Equity-to-Asset Historical Data

The historical data trend for Bavarian Nordic A/S's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bavarian Nordic A/S Equity-to-Asset Chart

Bavarian Nordic A/S Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.27 0.56 0.61 0.58 0.72

Bavarian Nordic A/S Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.58 0.69 0.65 0.70 0.72

Competitive Comparison of Bavarian Nordic A/S's Equity-to-Asset

For the Biotechnology subindustry, Bavarian Nordic A/S's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bavarian Nordic A/S's Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bavarian Nordic A/S's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Bavarian Nordic A/S's Equity-to-Asset falls into.



Bavarian Nordic A/S Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Bavarian Nordic A/S's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=10339.932/14353.213
=0.72

Bavarian Nordic A/S's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )=Total Stockholders Equity/Total Assets
=10339.932/14353.213
=0.72

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bavarian Nordic A/S  (OCSE:BAVA) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Bavarian Nordic A/S Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Bavarian Nordic A/S's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Bavarian Nordic A/S (OCSE:BAVA) Business Description

Traded in Other Exchanges
Address
Philip Heymans Alle 3, Hellerup, DNK, DK-2900
Bavarian Nordic A/S is a biotechnology company focused on the development, manufacturing, and commercialization of cancer immunotherapies and vaccines for infectious diseases. The company has a specific focus on diseases for which the unmet medical need is high. Bavarian generates revenue through government research and development and supply contracts, and from its commercial partnerships. The vast majority of the company's revenue is generated in the United States, Germany, and other geographic markets.

Bavarian Nordic A/S (OCSE:BAVA) Headlines

No Headlines